New Delhi: Pharma major Sun Pharmaceutical Industries reported a 59.19 percent dip in consolidated net profit to Rs 912.12 crore for the quarter ended on September 30, 2017, compared to the year-ago quarter.
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.
Consolidated total revenue from operations stood at Rs 6,650.34 crore. It was Rs 8,260.11 crore in the same period of previous year.
0 comment(s) on Sun Pharma Q2 net profit dives 59 percent at Rs 912.12 crore